Recent Finacing
Recent Raise
AccuLine develops CORA, a clinically validated, non‑invasive cardiac exam that uses enhanced waveform displays and AI to detect two electrical biomarkers, delivering results in under two minutes at point-of-care.
Focus Areas
Recent Investors
Funding round
Investor
See the team members at AccuLine.
